Supporting patient groups and continuously improving knowledge in our therapy areas is part of our corporate responsibility.
Our ultimate goal is to discover and develop innovative therapies to improve patients' quality of life.
We specialize in the treatment of life-threatening diseases. Our patients always come first.
We offer programs for patients, families and patient organizations worldwide. They help to improve the quality of medical care.
Welcome to CSL Innovation GmbH, the Research & Development team in Marburg.
We actively promote collaborations and partnerships to bring innovation to patients.
At CSL Behring, we work every day as if someone’s life depends on it, because it does.
CSL Behring's biotherapeutics are manufactured in state-of-the-art facilities under strictly controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
We want you to feel comfortable at CSL.
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
Information for the press, such as press releases and press contact.
Popular search terms:
CSL closes commercialization and license agreement for Hemophilia B gene therapy.
The future of rare disease diagnostics in the focus of science and industry
Last year’s “Cents for a good cause” will benefit children and young people with mental illnesses.
Marburg, Germany’s vibrant R&D ecosystem creates hope for patients and CSL Behring’s future.
“It’s such a joy to accompany a young person and to see her achieve something,” says Stephanie Fuchs.
Landmarks around the world were illuminated on Sunday in honor of rare disease patients.
Test your knowledge about rare diseases!
See the video Perreault shared with employees: “Reflect on the work we do and the people who count on us to keep innovating.”
Rare Disease Day sets a marker for the fate of patients
Americas
Asia Pacific
Middle East
Europe
